Skip to main content
Clinical Trials/JPRN-UMIN000007439
JPRN-UMIN000007439
Completed
Phase 1

The safety, efficacy and the predictive factors of efficacy of beclomethasone dipropionate (BDP) for acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation - The safety, efficacy and the predictive factors of efficacy of BDP for acute GVHD

Hematology,Graduate School of Medicine, Osaka City University0 sites26 target enrollmentMarch 5, 2012

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Hematologic disorders gastrointestinal acute GVHD
Sponsor
Hematology,Graduate School of Medicine, Osaka City University
Enrollment
26
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 5, 2012
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hematology,Graduate School of Medicine, Osaka City University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients requiring systemic steroid treatment for grade 2 acute GVHD of skin and/or liver 2\. Patients who cannot intake oral BDP 3\. Uncontrollable infection in the gastrointestinal tract 4\. Pregnant or possibility pregnant woman 5\. Inappropriate to participate in this study as judged by the physician in charge

Outcomes

Primary Outcomes

Not specified

Similar Trials